Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Novel Cell Sieve Reduces Risk of Contamination During Filtration of Cell Suspensions and Primary Cell Isolates

By BiotechDaily International staff writers
Posted on 15 Aug 2013
Image: EASYstrainer cell sieve for filtration of cell suspensions and primary cell isolates (Photo courtesy of Greiner Bio-One).
Image: EASYstrainer cell sieve for filtration of cell suspensions and primary cell isolates (Photo courtesy of Greiner Bio-One).
A novel sterile, single-use cell sieve is ideal for preparing single cells for flow cytometry and to separate individual cells after organ digestion as part of the primary cell extraction process.

Greiner Bio-One (Kremsmuenster, Austria), a company that has focused on the development, production, and distribution of plastic laboratory products, has introduced EASYstrainer, a cell sieve for the filtration of cell suspensions.

To prevent sterile filter material from becoming contaminated through accidental contact EASYstrainer was designed with a circumferential mantle surface and handle fitted directly on the sieve. The unit is sealed in blister packaging that ensures reliable, aseptic removal of sieves from the pack.

The EASYstrainer features a venting slot between the collection tube and the attached cell sieve. Air in the tube escapes through this slot during the rapid filtration step, and overflow is avoided. This special property prevents the accumulation of filtration liquid between the sieve and tube and thus the associated risk of contamination.

EASYstrainer is suitable for all standard 50 ml tubes and is available in mesh widths of 40, 70, and 100 microliters.

Related Links:
Greiner Bio-One


comments powered by Disqus

Channels

Genomics/Proteomics

view channel

New Program Encourages Wide Distribution of Genomic Data

A new data sharing program allows genomics researchers and practitioners to analyze, visualize, and share raw sequence data for individual patients or across populations straight from a local browser. The sequencing revolution is providing the raw data required to identify the genetic variants underlying rare diseases... Read more

Drug Discovery

view channel
Image: The nano-cocoon drug delivery system is biocompatible, specifically targets cancer cells, can carry a large drug load, and releases the drugs very quickly once inside the cancer cell. Ligands on the surface of the \"cocoon\" trick cancer cells into consuming it. Enzymes (the “worms\" in this image) inside the cocoon are unleashed once inside the cell, destroying the cocoon and releasing anticancer drugs into the cell (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Novel Anticancer Drug Delivery System Utilizes DNA-Based Nanocapsules

A novel DNA-based drug delivery system minimizes damage to normal tissues by utilizing the acidic microenvironment inside cancer cells to trigger the directed release of the anticancer drug doxorubicin (DOX).... Read more

Lab Technologies

view channel

Experimental Physicists Find Clues into How Radiotherapy Kills Cancer Cells

A new discovery in experimental physics has implications for a better determination of the process in which radiotherapy destroys cancer cells. Dr. Jason Greenwood from Queen’s University Belfast (Ireland) Center for Plasma Physics collaborated with scientists from Italy and Spain on the work on electrons, and published... Read more

Business

view channel

Interest in Commercial Applications for Proteomics Continues to Grow

Increasing interest in the field of proteomics has led to a series of agreements between private proteomic companies and academic institutions as well as deals between pharmaceutical companies and novel proteomics innovator biotech companies. Proteomics is the study of the structure and function of proteins.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.